Samorita Hospital Limited announcements
287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (25).
- Dr. A. B. M. Haroon, one of the Sponsor Directors of the company, has expressed his intention to sell 1,00,000 shares ou
Dr. A. B. M. Haroon, one of the Sponsor Directors of the company, has expressed his intention to sell 1,00,000 shares out of his holding of 14,75,621 shares of the company at prevailing market price (in the Public and Block Market) through Dhaka Stock Exchange Limited within next 30 working days.
- Trading of the shares of the company will resume on 10.12.2023.
Trading of the shares of the company will resume on 10.12.2023.
- Trading of the shares of the company will remain suspended on record date i.e., 07.12.2023.
Trading of the shares of the company will remain suspended on record date i.e., 07.12.2023.
- Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 05.12.2023 to 06.12.2023 and trading of the shares will remain suspended on record date i.e., 07.12.2023 for entitlement of the Bonus Shares.
- Refer to the earlier news disseminated by DSE on 29.10.2023 and 16.11.2023 regarding dividend declaration for the year e
Refer to the earlier news disseminated by DSE on 29.10.2023 and 16.11.2023 regarding dividend declaration for the year ended June 30, 2023, the Company has further informed that BSEC has accorded its consent for issuance of 10\% Stock Dividend for the year ended June 30, 2023. The company has fixed the Record date on 07.12.2023 for entitlement of the aforesaid Bonus Shares.
- Credit Rating Agency of Bangladesh Limited (CRAB) has assigned the entity rating of the Company as \"A3\" in the long te
Credit Rating Agency of Bangladesh Limited (CRAB) has assigned the entity rating of the Company as \"A3\" in the long term along with Stable outlook based on audited financial statements as of FY June 30, 2023, Bank liability position as on October 29, 2023 and other information up to the date of rating declaration.
- Resumption after record date
Trading of the shares of the company will resume on 21.11.2023.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 20.11.2023.
- Regarding the stock dividend declared by the company
Refer to the earlier news disseminated by DSE on 29.10.2023 regarding dividend declaration for the year ended June 30, 2023, the company has further informed that their recommendation of 10% stock dividend is subject to the approval of Bangladesh Securities and Exchange Commission. The company is yet to receive the consent of the Commission.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 16.11.2023 to 19.11.2023 and trading of the shares will remain suspended on record date i.e., 20.11.2023.
- (Q1 Un-audited): EPS was Tk. 0.92 for July-September 2023 as against Tk. 0.14 for July-September 2022; NOCFPS was Tk. 2.
(Q1 Un-audited): EPS was Tk. 0.92 for July-September 2023 as against Tk. 0.14 for July-September 2022; NOCFPS was Tk. 2.01 for July-September 2023 as against Tk. 0.88 for July-September 2022. NAV per share was Tk. 55.19 as on September 30, 2023 and Tk. 48.39 as on June 30, 2023. (cont.)
- The Board of Directors has recommended 10\% Stock dividend for the year ended June 30, 2023. Date of AGM: 19.12.2023, Ti
The Board of Directors has recommended 10\% Stock dividend for the year ended June 30, 2023. Date of AGM: 19.12.2023, Time: 12:00 PM, Venue: Digital Platform. Record date: 20.11.2023. The Company has also reported EPS of Tk. 0.04, NAV per share of Tk. 48.39 and NOCFPS of Tk. 1.34 for the year ended June 30, 2023 as against Tk. 0.82, Tk. 48.88 and Tk. 1.77 respectively for the year ended June 30, 2022. The Board of Directors in the same meeting also adopted the Valuation Report of Freehold Land of (cont.1)
- (Continuation news of SAMORITA): Samorita Hospital Ltd. prepared by Basu Banerjee Nath & Co. Chartered Accountants as de
(Continuation news of SAMORITA): Samorita Hospital Ltd. prepared by Basu Banerjee Nath & Co. Chartered Accountants as detailed below. Area of land (Decimal): 28.66, 3.6 and 6.8 (Total- 39.06), Total Cost: Tk. 95,628,231.00, Revaluation gain (As per revaluation of the year 2013): Tk. 664,617,959.00, Book Value as on 30th June 2022: Tk. 760,246,190.00, Current Value as per revaluation on 30th September 2023: Tk. 884,344,886.00 and Revaluation gain: Tk. 124,098,696.00. Disclosures for recommending (cont.2)
The first part of this announcement is missing from the archive. - (Continuation news of SAMORITA): stock dividend: a) Bonus shares have been recommended out of the retained amount of the
(Continuation news of SAMORITA): stock dividend: a) Bonus shares have been recommended out of the retained amount of the company as capital for re-investment in the business/better working capital management of the Company. b) Bonus shares is declared out of accumulated profit of the company. (cont.3)
The first part of this announcement is missing from the archive. - Dividend Declaration
(Continuation news of SAMORITA): c) Bonus shares is not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Q1 Financials
(Continuation news of SAMORITA): Reasons for significant deviation in NOCFPS and NAVPS: NOCFPS increased from Tk. 0.88 to Tk. 2.01 due to Cash receipts from Customers have been increased by Tk. 3.07 Crore. NAVPS increased by Tk. 6.80 due to revaluation gain on land & usual business activities of the company. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2023 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2023 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.10 for January-March 2023 as against Tk. 0.01 for January-March 2022; EPS was Tk. 0.44 for July 2022-March 2023 as against Tk. 1.21 for July 2021-March 2022. NOCFPS was Tk. 1.95 for July 2022-March 2023 as against Tk. 1.93 for July 2021-March 2022. NAV per share was Tk. 48.84 as on March 31, 2023 and Tk. 48.88 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2023 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares to the respective shareholders' BO Accounts and it has also disbursed the cash dividend to the respective shareholders for the year ended June 30, 2022.
- (Q2 Un-audited): EPS was Tk. 0.20 for October-December 2022 as against Tk. 0.18 for October-December 2021, EPS was Tk. 0
(Q2 Un-audited): EPS was Tk. 0.20 for October-December 2022 as against Tk. 0.18 for October-December 2021, EPS was Tk. 0.34 for July-December 2022 as against Tk. 1.20 for July-December 2021. NOCFPS was Tk. 1.32 for July-December 2022 as against Tk. 1.81 for July-December 2021. NAV per share was Tk. 48.74 as on December 31, 2022 and Tk. 48.88 as on June 30, 2022. (Cont.)
- Q2 Financials
(Continuation news of SAMORITA): The Company has also informed that Operating result in the reporting has been significantly decreased due to decrease in revenue and increase in operating expenses. NOCFPS has been decreased due to decrease in cash receipts from customers as well as increase in cash paid to suppliers and employees. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2023 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.